Envista Holdings Corporation Stock News

Henry Schein (HSIC) stock rallies on strong fourth-quarter performance and bullish 2022 EPS guidance.

Syneos Health (SYNH) reports better-than-expected earnings for the fourth quarter and strong performances by the Clinical Solutions and Commercial Solutions arms.

Strength in Musculoskeletal Solutions and Enabling Technologies products drove Globus Medical's (GMED) Q4 revenues.

Here is how Indivior PLC (INVVY) and Envista (NVST) have performed compared to their sector so far this year.

Envista Holdings Corp (NVST) shares closed 2.8% higher than its previous 52 week high, giving the company a market cap of $7B. The stock is currently up 7.0% year-to-date, up 19.5% over the past 12 months, and up 72.6% over the past five years. This week, the Dow Jones Industrial Average fell 1.2%, and the S&P 500 fell 1.1%. Trading Activity Trading volume this week was 9.1% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 632.1% The company's stock price performance over the past 12 months beats the peer average by -199.8% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 228.2% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Envista Holdings Corp (NVST) shares closed today at 0.3% below its 52 week high of $48.38, giving the company a market cap of $7B. The stock is currently up 4.0% year-to-date, up 16.1% over the past 12 months, and up 67.7% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.8%. Trading Activity Trading volume this week was 0.4% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -259.9% The company's stock price performance over the past 12 months beats the peer average by -175.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 235.1% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Robust performances by all three operating businesses drove Henry Schein's (HSIC) Q4 revenues.

Robust performance by the Product and Service segments is driving Omnicell's (OMCL) fourth-quarter top line.

Are these on your list of best health care stocks to buy right now?

Envista Holdings Corp (NVST) shares closed 0.6% higher than its previous 52 week high, giving the company a market cap of $7B. The stock is currently down 2.3% year-to-date, up 13.1% over the past 12 months, and up 57.6% over the past five years. This week, the Dow Jones Industrial Average rose 0.5%, and the S&P 500 rose 0.0%. Trading Activity Trading volume this week was 15.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 2068.2% The company's stock price performance over the past 12 months beats the peer average by -163.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 212.9% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Gainers: Dermata Therapeutics DRMA +35%. Innoviva (INVA) +11%. Mainz Biomed (MYNZ) +9%. Regional Health Properties RHE +9%. Envista Holdings (NVST) +8%.Losers: InfuSystem

Envista (NVST) delivered earnings and revenue surprises of 9.52% and 2.94%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Shares of Envista Holdings Corp. are up 4% in after-hours trading after the company Q4 2021 results beat on both the top and bottom line.

Envista press release (NVST): Q4 Non-GAAP EPS of $0.46 beats by $0.04.Revenue of $651.8M (+5.8% Y/Y) beats by $17.12M.For 2022, barring any significant COVID related disruptions,…